These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 11922591)
1. Spontaneous regression of hepatocellular carcinoma associated with elevated levels of interleukin 18. Abiru S; Kato Y; Hamasaki K; Nakao K; Nakata K; Eguchi K Am J Gastroenterol; 2002 Mar; 97(3):774-5. PubMed ID: 11922591 [No Abstract] [Full Text] [Related]
2. Hepatocellular carcinoma with spontaneous regression: report of the rare case. Arakawa Y; Mori H; Ikegami T; Hanaoka J; Kanamoto M; Kanemura H; Morine Y; Imura S; Shimada M Hepatogastroenterology; 2008; 55(86-87):1770-2. PubMed ID: 19102389 [TBL] [Abstract][Full Text] [Related]
3. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C. Kitaoka S; Shiota G; Kawasaki H Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788 [TBL] [Abstract][Full Text] [Related]
4. [Hepatocellular carcinoma and hyperestrogenia in a male]. Salles G; Vital Durand D; Mackiewicz R; Pugeat M; Levrat R Gastroenterol Clin Biol; 1987; 11(8-9):607-9. PubMed ID: 2820825 [TBL] [Abstract][Full Text] [Related]
5. Elevated serum chromogranin A in patients with hepatocellular carcinoma. Leone N; Pellicano R; Brunello F; Rizzetto M; Ponzetto A Clin Exp Med; 2002 Nov; 2(3):119-23. PubMed ID: 12447608 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma. Hsia CY; Huo TI; Chiang SY; Lu MF; Sun CL; Wu JC; Lee PC; Chi CW; Lui WY; Lee SD Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760 [TBL] [Abstract][Full Text] [Related]
7. Patients with advanced primary hepatocellular carcinoma treated by melatonin and transcatheter arterial chemoembolization: a prospective study. Yan JJ; Shen F; Wang K; Wu MC Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):183-6. PubMed ID: 14607735 [TBL] [Abstract][Full Text] [Related]
8. Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma. Mattera D; Capuano G; Colao A; Pivonello R; Manguso F; Puzziello A; D'Agostino L Clin Endocrinol (Oxf); 2003 Dec; 59(6):699-706. PubMed ID: 14974910 [TBL] [Abstract][Full Text] [Related]
9. Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets. Beckebaum S; Zhang X; Chen X; Yu Z; Frilling A; Dworacki G; Grosse-Wilde H; Broelsch CE; Gerken G; Cicinnati VR Clin Cancer Res; 2004 Nov; 10(21):7260-9. PubMed ID: 15534100 [TBL] [Abstract][Full Text] [Related]
10. Spontaneous regression of hepatocellular carcinoma. Herrera A; Erdozain JC; Molina E; Conde P; Palomo V Am J Gastroenterol; 1996 Jun; 91(6):1288-9. PubMed ID: 8651210 [No Abstract] [Full Text] [Related]
11. Vascular endothelial growth factor receptor-1 levels in hepatocellular carcinoma and correlations with clinicopathological features. Yolcu OF; Köklü S; Yüksel O; Coban S; Ayaz S; Akif Oztürk M; Benekli M Hepatogastroenterology; 2007; 54(77):1526-8. PubMed ID: 17708290 [TBL] [Abstract][Full Text] [Related]
12. Clarification of risk factors for hepatectomy in patients with hepatocellular carcinoma. Ishikawa M; Yogita S; Miyake H; Fukuda Y; Harada M; Wada D; Tashiro S Hepatogastroenterology; 2002; 49(48):1625-31. PubMed ID: 12397750 [TBL] [Abstract][Full Text] [Related]
13. [Regression of hepatocellular carcinoma under Tamoxifen: report of one case and review of the literature]. Macaigne G; Auriault ML; Boivin JF; Cheaib S; Chayette C; Deplus R Gastroenterol Clin Biol; 2002 Dec; 26(12):1165-7. PubMed ID: 12520204 [TBL] [Abstract][Full Text] [Related]
14. Addressing the interplay of liver disease and hepatocellular carcinoma on patient survival: the ALBI scoring model. Knox JJ J Clin Oncol; 2015 Feb; 33(6):529-31. PubMed ID: 25512460 [No Abstract] [Full Text] [Related]
15. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208 [TBL] [Abstract][Full Text] [Related]
16. Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patients. Alisa A; Ives A; Pathan AA; Navarrete CV; Williams R; Bertoletti A; Behboudi S Clin Cancer Res; 2005 Sep; 11(18):6686-94. PubMed ID: 16166448 [TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinoma. Scholz A; Rehm VA; Rieke S; Derkow K; Schulz P; Neumann K; Koch I; Pascu M; Wiedenmann B; Berg T; Schott E Am J Gastroenterol; 2007 Nov; 102(11):2471-81. PubMed ID: 17581268 [TBL] [Abstract][Full Text] [Related]
18. Spontaneous regression of hepatocellular carcinoma. A case report. Clos A; Hernández A; Sánchez MD; Tenesa M; Julián JF; Armengol C; Sala M Gastroenterol Hepatol; 2017 Apr; 40(4):286-288. PubMed ID: 26994525 [No Abstract] [Full Text] [Related]
19. [Vascular elasticity in patients with spontaneous rupture of hepatocellular carcinoma]. Zhu L; Geng X; Fan S Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):96. PubMed ID: 11983121 [No Abstract] [Full Text] [Related]